Menu
Back to User profile » Professor Claus Vogelmeier
Papers published by Professor Claus Vogelmeier:
New Perspectives on Chronic Obstructive Pulmonary Disease
Celli BR, Singh D, Vogelmeier C, Agusti A
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2127-2136
Published Date: 6 September 2022
COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
Vogelmeier CF, Diesing J, Kossack N, Pignot M, Friedrich FW
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2407-2417
Published Date: 24 August 2021
Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
Lutter JI, Jörres RA, Welte T, Watz H, Waschki B, Alter P, Trudzinski FC, Ohlander J, Behr J, Bals R, Studnicka M, Holle R, Vogelmeier CF, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2787-2798
Published Date: 5 November 2020
Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study
Voorham J, Baldi S, Santoro L, Kerkhof M, Contoli M, Fabbri LM, Kerstjens HAM, Luis López-Campos J, Roche N, Singh D, Vogelmeier CF, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2739-2750
Published Date: 29 October 2020
Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients
Kostikas K, Mackay AJ, Vogelmeier CF, Frent SM, Gupta P, Banerji D, Patalano F, Pfister PJ, Wedzicha JA
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1831-1838
Published Date: 28 July 2020
Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology
Veith M, Klemmer A, Anton I, El Hamss R, Rapun N, Janciauskiene S, Kotke V, Herr C, Bals R, Vogelmeier CF, Greulich T
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2535-2542
Published Date: 18 November 2019
Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K
Patient Preference and Adherence 2019, 13:1711-1721
Published Date: 10 October 2019
Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
Alter P, Mayerhofer BA, Kahnert K, Watz H, Waschki B, Andreas S, Biertz F, Bals R, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2163-2172
Published Date: 20 September 2019
Personalized medicine for patients with COPD: where are we?
Franssen FME, Alter P, Bar N, Benedikter BJ, Iurato S, Maier D, Maxheim M, Roessler FK, Spruit MA, Vogelmeier CF, Wouters EFM, Schmeck B
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1465-1484
Published Date: 9 July 2019
Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
Byng D, Lutter JI, Wacker ME, Jörres RA, Liu X, Karrasch S, Schulz H, Vogelmeier C, Holle R
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1423-1439
Published Date: 5 July 2019
Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
Vestbo J, Vogelmeier CF, Small M, Siddall J, Fogel R, Kostikas K
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:853-861
Published Date: 16 April 2019
Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
Greulich T, Mager S, Lucke T, Koczulla AR, Bals R, Fähndrich S, Jörres RA, Alter P, Kirsten A, Vogelmeier CF, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2999-3002
Published Date: 28 September 2018
Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study
Buhl R, Criée C, Kardos P, Vogelmeier CF, Kostikas K, Lossi NS, Worth H
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2557-2568
Published Date: 24 August 2018
Influence of body mass on predicted values of static hyperinflation in COPD
Alter P, Rabe KF, Schulz H, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2551-2555
Published Date: 23 August 2018
COPD as a risk factor of the complications in lower limb arthroplasty: a patient-matched study
Klasan A, Dworschak P, Heyse TJ, Ruchholtz S, Alter P, Vogelmeier C, Schwarz Patrick
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2495-2499
Published Date: 21 August 2018
Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA
Kardos P, Mokros I, Sauer R, Vogelmeier CF
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1455-1468
Published Date: 3 May 2018
Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study
Greulich T, Kostikas K, Gaga M, Aalamian-Mattheis M, Lossi NS, Patalano F, Nunez X, Pagano VA, Fogel R, Vogelmeier CF, Clemens A
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1229-1237
Published Date: 16 April 2018
Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
Vogelmeier CF, Chapman KR, Miravitlles M, Roche N, Vestbo J, Thach C, Banerji D, Fogel R, Patalano F, Olsson P, Kostikas K, Wedzicha JA
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1125-1134
Published Date: 10 April 2018
The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
Wacker ME, Kitzing K, Jörres RA, Leidl R, Schulz H, Karrasch S, Karch A, Koch A, Vogelmeier CF, Holle R
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3437-3448
Published Date: 4 December 2017
Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study
Celli B, Blasi F, Gaga M, Singh D, Vogelmeier C, Pegoraro V, Caputo N, Agusti A
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2189-2196
Published Date: 27 July 2017
Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency – analysis from the German Registry
Bernhard N, Lepper PM, Vogelmeier C, Seibert M, Wagenpfeil S, Bals R, Fähndrich S
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1427-1437
Published Date: 12 May 2017
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
Anzueto AR, Vogelmeier CF, Kostikas K, Mezzi K, Fucile S, Bader G, Shen S, Banerji D, Fogel R
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1325-1337
Published Date: 4 May 2017
“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
Vogelmeier C, Worth H, Buhl R, Criée C, Lossi NS, Mailänder C, Kardos P
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:487-494
Published Date: 1 February 2017
Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis
Vogelmeier C, Zhong NS, Humphries MJ, Mezzi K, Fogel R, Bader G, Patalano F, Banerji D
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3189-3197
Published Date: 14 December 2016
A year in the life of German patients with COPD: the DACCORD observational study
Buhl R, Criée CP, Kardos P, Vogelmeier C, Lossi N, Mailänder C, Worth H
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1639-1646
Published Date: 20 July 2016
Highlights and hot topics in the management of COPD: where are we heading?
Agustí A, Jones PW, Vogelmeier C
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1-2
Published Date: 18 February 2016
The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency
Schmid ST, Koepke J, Dresel M, Hattesohl A, Frenzel E, Perez J, Lomas DA, Miranda E, Greulich T, Noeske S, Wencker M, Teschler H, Vogelmeier C, Janciauskiene S, Koczulla AR
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:687-696
Published Date: 28 September 2012